ES2149791T3 - Procedimiento para la inactivacion de virus en preparaciones de proteinas. - Google Patents

Procedimiento para la inactivacion de virus en preparaciones de proteinas.

Info

Publication number
ES2149791T3
ES2149791T3 ES93106848T ES93106848T ES2149791T3 ES 2149791 T3 ES2149791 T3 ES 2149791T3 ES 93106848 T ES93106848 T ES 93106848T ES 93106848 T ES93106848 T ES 93106848T ES 2149791 T3 ES2149791 T3 ES 2149791T3
Authority
ES
Spain
Prior art keywords
viruses
inactivation
procedure
protein preparations
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93106848T
Other languages
English (en)
Other versions
ES2149791T5 (es
Inventor
Hermann Keuper
Walter Matzmorr
Wilfried Freudenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25915149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2149791(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Application granted granted Critical
Publication of ES2149791T3 publication Critical patent/ES2149791T3/es
Publication of ES2149791T5 publication Critical patent/ES2149791T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32661—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA INVENCION TRATA DE UN PROCEDIMIENTO PARA INACTIVAR LOS VIRUS EN UN SOLUCION DE PROTEINAS A TRAVES DE CALENTAMIENTO DE LA SOLUCION DURANTE PEQUEÑOS INTERVALOS DE TIEMPO.
ES93106848T 1992-05-26 1993-04-28 Procedimiento para la inactivacion de virus en preparaciones de proteinas. Expired - Lifetime ES2149791T5 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4217355 1992-05-26
DE4217355 1992-05-26
DE4240103A DE4240103A1 (de) 1992-05-26 1992-11-28 Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen
DE4240103 1992-11-28

Publications (2)

Publication Number Publication Date
ES2149791T3 true ES2149791T3 (es) 2000-11-16
ES2149791T5 ES2149791T5 (es) 2005-05-16

Family

ID=25915149

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93106848T Expired - Lifetime ES2149791T5 (es) 1992-05-26 1993-04-28 Procedimiento para la inactivacion de virus en preparaciones de proteinas.

Country Status (8)

Country Link
EP (1) EP0571771B2 (es)
JP (1) JP3650410B2 (es)
KR (1) KR940005805A (es)
AT (1) ATE194648T1 (es)
AU (1) AU3876793A (es)
CA (1) CA2096888C (es)
DE (2) DE4240103A1 (es)
ES (1) ES2149791T5 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19720853A1 (de) 1997-05-17 1998-11-19 Dade Behring Marburg Gmbh Erhöhung der FVII Empfindlichkeit eines Thromboplastinreagenzes
NL1016029C2 (nl) * 2000-08-28 2002-03-01 Gelatine Smits Beheer B V Werkwijze om ziekteveroorzakers uit te schakelen onder toepassing van verhitting.
CA2429574C (en) * 2000-11-24 2009-02-10 Breath Limited Sterilisation of pharmaceuticals
EP3286295A1 (en) * 2015-04-20 2018-02-28 GE Healthcare Bio-Sciences Corp. Inactivation of viruses
US11052165B2 (en) 2015-04-20 2021-07-06 Global Life Sciences Solutions Usa Llc Method for virus clearance
US10323494B2 (en) 2015-07-23 2019-06-18 General Electric Company Hydrocarbon production system and an associated method thereof
US10077646B2 (en) 2015-07-23 2018-09-18 General Electric Company Closed loop hydrocarbon extraction system and a method for operating the same
US10047596B2 (en) 2015-07-23 2018-08-14 General Electric Company System and method for disposal of water produced from a plurality of wells of a well-pad

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3473407D1 (en) * 1983-05-02 1988-09-22 Immuno Ag Method of inactivating pathogens
US4695454A (en) * 1985-04-01 1987-09-22 New York Blood Center, Inc. Process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
DE3905066A1 (de) * 1989-02-18 1990-08-23 Behringwerke Ag Waermetauschermodul
FR2664165B1 (fr) * 1990-07-03 1992-10-16 Lille Transfusion Sanguine Composition pour stabiliser le plasma sanguin en cours de pasteurisation.

Also Published As

Publication number Publication date
AU3876793A (en) 1993-12-02
EP0571771A2 (de) 1993-12-01
ES2149791T5 (es) 2005-05-16
CA2096888C (en) 2004-04-27
EP0571771B1 (de) 2000-07-12
EP0571771A3 (en) 1994-07-06
KR940005805A (ko) 1994-03-22
CA2096888A1 (en) 1993-11-27
EP0571771B2 (de) 2004-10-20
JPH0665091A (ja) 1994-03-08
ATE194648T1 (de) 2000-07-15
DE59310073D1 (de) 2000-08-17
DE4240103A1 (de) 1993-12-02
JP3650410B2 (ja) 2005-05-18

Similar Documents

Publication Publication Date Title
ES2087156T3 (es) Metodos para la inactivacion de virus en composiciones farmaceuticas contaminadas por virus.
ES552985A0 (es) Procedimiento fotodinamico de inactivacion de virus
ES2101077T5 (es) Procedimiento para la inactivacion de priones.
DE69637181D1 (de) Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
PT759935E (pt) L1 de virus de papiloma recombinante
ES511668A0 (es) "metodo para inactivar los virus infecciosos contenidos en una composicion enzimatica hemocoagulante".
ATE217144T1 (de) Verfahren und zusammensetzungen zur selektiven modifikation von nukleinsaeuren
ATE215125T1 (de) ßHEAT SHOCKß-PROTEINE UND BEHANDLUNG VON TUMOREN
ATE150319T1 (de) Behandlung von asthma
NO831317L (no) Fremgangsmaate for fremstilling av funksjonelle menneske-urokinase proteiner.
DK0383234T3 (da) Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling
NO951761L (no) Stabilt preparat for behandling av blodkoagulasjonssykdommer
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
FI885504A (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
DE69327755D1 (de) Zusammensetzung zum Unterdrücken von Infektion und Wachstum des menschlichen Immunschwäche-Virus unter Verwendung eines eisenbindenden Proteins
ES2149791T3 (es) Procedimiento para la inactivacion de virus en preparaciones de proteinas.
ES2117703T3 (es) Preparacion de factor viii.
ES2165884T3 (es) Preparacion farmaceutica estable que no contiene actividad viral consistente en al menos un 70%, preferiblemente un 90% de inmunoglobulina a humana monomera, y procedimiento de preparacion.
DK406184A (da) Fremgangsmaade til pasteurisering af humanplasma
ES2113910T3 (es) Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus.
ATE298582T1 (de) Verfahren zur inaktivierung von viren und lyophilisierung von blutproteinen
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
ATE356144T1 (de) Regulatorische/entfaltende peptide von ezrin
DK0457035T3 (da) Fremgangsmåde til inaktivering af den biologiske aktivitet af DNA
DE59309355D1 (de) Neue Phospholipidderivate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 571771

Country of ref document: ES